ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

INVA Innoviva Inc

15.26
0.27 (1.80%)
2024年4月27日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Innoviva Inc INVA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.27 1.80% 15.26 06:16:11
始値 安値 高値 終値 前日終値
15.01 14.98 15.285 15.26 14.99
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2420:00BWInnoviva Specialty Therapeutics’ Positive Phase 3 Oral..
2024/3/0809:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0809:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0809:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0808:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0107:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0106:15EDGAR2Form 8-K - Current report
2024/3/0106:05BWInnoviva Reports Fourth Quarter and Full Year 2023 Financial..
2024/2/2311:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2311:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1421:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2311:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1110:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/11/1806:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/0622:30EDGAR2Form 8-K - Current report
2023/11/0205:30EDGAR2Form 8-K - Current report
2023/11/0205:15BWInnoviva Reports Third Quarter 2023 Financial Results and..
2023/11/0205:05BWPositive Results Announced in Largest Pivotal Phase 3 Trial..
2023/9/1921:30BWInnoviva to Participate in the Cantor Global Healthcare..
2023/9/1821:00BWXACDURO®, The First and Only Antibiotic Developed to Target..
2023/9/0109:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/0102:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2606:24EDGAR2Form 8-K - Current report
2023/8/2605:52BWInnoviva Appoints Stephen Basso as Chief Financial Officer
2023/8/0805:42EDGAR2Form 8-K - Current report
2023/8/0310:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0305:15EDGAR2Form 8-K - Current report
2023/8/0305:05BWInnoviva Reports Second Quarter 2023 Financial Results and..
2023/7/1121:16EDGAR2Form 8-K - Current report
2023/6/0705:05BWInnoviva to Participate in the Goldman Sachs Annual Global..
2023/5/2408:10DJNFDA Approves Innoviva's Bacterial Pneumonia Treatment
2023/5/2407:42BWInnoviva Specialty Therapeutics Announces FDA Approval for..
2023/5/1207:45BWResults from Pivotal Phase 3 ATTACK Trial of Investigational..
2023/5/1005:32BWInnoviva Reports First Quarter 2023 Financial Results and..
2023/4/2906:30BWInnoviva Announces Retirement of Board Chairman

最近閲覧した銘柄

Delayed Upgrade Clock